Tenaya Therapeutics, Inc.
News
Tenaya Therapeutics to Participate in Upcoming Investment Conferences
Globe Newswire SOUTH SAN FRANCISCO, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver...\n more…
Head to Head Survey: Tenaya Therapeutics (NASDAQ:TNYA) and AlloVir (NASDAQ:ALVR)
Ticker Report Tenaya Therapeutics (NASDAQ:TNYA - Get Free Report) and AlloVir (NASDAQ:ALVR - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two...\n more…
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Insider Whittemore Tingley Sells 7,428 Shares
Ticker Report Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Get Free Report) insider Whittemore Tingley sold 7,428 shares of the firm's stock in a transaction that occurred on Friday, August 16th. The stock was sold at...\n more…
Insider Selling: Tenaya Therapeutics, Inc. (NASDAQ:TNYA) CEO Sells 9,748 Shares of Stock
Ticker Report Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Get Free Report) CEO Faraz Ali sold 9,748 shares of Tenaya Therapeutics stock in a transaction that occurred on Friday, August 16th. The stock was sold at an...\n more…
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Consensus Rating of "Buy" by Brokerages
Ticker Report Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Get Free Report) has been given an average rating of "Buy" by the six analysts that are currently covering the firm, MarketBeat Ratings reports. Six equities...\n more…